AI assistant
AtriCure, Inc. — Director's Dealing 2020
Feb 13, 2020
31802_dirs_2020-02-13_d988eadf-6f71-4ab8-84ba-e828aa355332.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-02-11
Reporting Person: Seith Douglas J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-11 | Common Stock | M | 50000 | $21.04 | Acquired | 201299 | Direct |
| 2020-02-11 | Common Stock | F | 35059 | $42.00 | Disposed | 162740 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-11 | Stock Option (right to buy) | $21.04 | M | 50000 | Disposed | 2024-01-24 | Common stock (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3500 | Indirect |
Footnotes
F1: These shares were exercised pursuant to a 10b5-1 trading plan.
F2: These shares were sold pursuant to a 10b5-1 trading plan.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F4: These options were granted on January 24, 2014. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.